Cover Image

Fluorescent in Situ Hybridization and Real-Time Quantitative Polymerase Chain Reaction to Evaluate HER-2/neu Status in Breast Cancer

Background:Breast cancer remains the most common and second lethal cancer in females. HER-2/neu is one of the most important amplified oncogene in breast cancer. The amplification of HER-2 is correlated with decreased survival, metastasis, and early recurrence. The amplification of HER-2/neu gene a...

Full description

Saved in:

Bibliographic Details
Main Authors:	Fatemeh Homaei Shandiz (Author), Azar Fani (Author), Sepideh Shakeri (Author), Maryam Sheikhi (Author), Abouzar Ramezani Farkhani (Author), Arezoo Shajiei (Author), Hossein Ayatollahi (Author)
Format:	Book
Published:	Iranian Society of Pathology, 2017-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Chromogenic in situ Hybridization Compared with Real Time Quantitative Polymerase Chain Reaction to Evaluate HER2/neu Status in Breast Cancer
by: Hossein Ayatollahi, et al.
Published: (2017)

Comparison of Immunohistochemical and Fluorescence In Situ Hybridization Assessment for HER-2/neu Status in Taiwanese Breast Cancer Patients
by: Shou-Jen Kuo, et al.
Published: (2007)

Dual-color dual-hapten in situ hybridization (D-DISH) - Comparison with fluorescence in situ hybridization (FISH) for HER2/neu testing in breast cancer
by: Pooja K Gajaria, et al.
Published: (2020)

Correlation of HER2/neu Over Expression, p53 Protein Accumulation and Steroid Receptor Status with Tumor Characteristics: An Iranian Study of Breast Cancer Patients
by: M Moradi-Marjaneh, et al.
Published: (2008)

Correlation of HER2/neu Over Expression, p53 Protein Accumulation and Steroid Receptor Status with Tumor Characteristics: An Iranian Study of Breast Cancer Patients
by: M Moradi-Marjaneh, et al.
Published: (2008)

Assessment of HER2/Neu status by fluorescence in situ hybridization in immunohistochemistry-equivocal cases of invasive ductal carcinoma and aberrant signal patterns: A study at a tertiary cancer center
by: Sudha S Murthy, et al.
Published: (2011)

HER 2 status in invasive breast cancer: Immunohistochemistry, fluorescence in-situ hybridization and chromogenic in-situ hybridization
by: Hemlata S Shirsat, et al.
Published: (2012)

LED-FISH: Fluorescence microscopy based on light emitting diodes for the molecular analysis of Her-2/neu oncogene amplification
by: Vollmer Ekkehard, et al.
Published: (2008)

Expression of HER2/neu in gastric adenocarcinoma and its correlation with serum HER2/neu level and E-cadherin expression
by: Ishan Pandey, et al.
Published: (2022)

Expression of Her-2/neu in extrahepatic cholangiocarcinoma
by: Shamekh R, et al.
Published: (2017)

Correlation and comparison of immunohistochemistry for HER2/neu, using the antibody SP3 and chromogenic in situ hybridization in breast carcinomas samples
by: Franciele F. Wolf, et al.
Published: (2015)

Role of HER2neu expression in gastric cancer
by: J S Sukanya, et al.
Published: (2021)

Rapid positive confirmation of mosaicism for a small supernumerary marker chromosome as r(8) by interphase fluorescence in situ hybridization, quantitative fluorescent polymerase chain reaction, and array comparative genomic hybridization on uncultured amniocytes in a pregnancy with fetal pyelectasis
by: Chih-Ping Chen, et al.
Published: (2012)

Polymerase Chain Reaction
Published: (2012)

The epidemiology of Her-2/ neu and P53 in breast cancer
by: Bernstein Jonine L., et al.
Published: (1999)

Evaluation Of Immunohistochemical Expression Of Her2/Neu In Prostate Adenocarcinoma
by: Santosh Kumar Sidhwani, et al.
Published: (2024)

Reproducibility in the automated quantitative assessment of HER2/neu for breast cancer
by: Tyler Keay, et al.
Published: (2013)

HER-2/neu expression in lesions of uterine cervix: Is it reliable and consistent?
by: Gupta Nidhi, et al.
Published: (2009)

Polymerase chain reaction in endodontics
Published: (2011)

Clinical application of the HM-1000 image processing for HER2 fluorescence in situ hybridization signal quantification in breast cancer
by: Vicente Peg, et al.
Published: (2024)

The epidemiology of Her-2/ neu and P53 in breast cancer Epidemiología de los genes Her2/neu y P53 en relación al cáncer mamario
by: Jonine L. Bernstein, et al.
Published: (1999)

Study of Epstein-Barr virus expression in Burkitt's lymphoma by polymerase chain reaction and in situ hybridization: A study in Iran
by: Parviz Deyhimi, et al.
Published: (2014)

Her-2 neu negative lipid rich breast carcinoma in an immunocompromised patient
by: Deepika Sirohi, M.D, et al.
Published: (2015)

Correlation between HER2 gene amplification and protein overexpression through fluorescence in situ hybridization and immunohistochemistry in breast carcinoma patients
by: R N Makroo, et al.
Published: (2012)

Polymerase Chain Reaction for Biomedical Applications
Published: (2016)

Inter-observer agreement in reporting HER 2 Neu protein over expression by immunohistochemistry
by: Ibrahim Al Haddabi, et al.
Published: (2014)

cERBB-2/Her-2 Neu Overexpression and Prognostic Significance in Uterine Carcinosarcoma
by: Huseyin Salih SEMIZ, et al.
Published: (2023)

Correlation of histological grade with Estrogen, Progesterone and HER2/neu reactivity in breast cancer
by: Girishma Shrestha, et al.
Published: (2019)

Development of automated brightfield double <it>In Situ </it>hybridization (BDISH) application for <it>HER2 g</it>ene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color <it>HER2 </it>fluorescence <it>In Situ </it>hybridization (FISH)
by: Wang Lin, et al.
Published: (2008)

HER2/Neu Expression was Different between Benign, Borderline and Malignant Epithelial Ovarian Tumors
by: Yona S. Hadisubroto, et al.
Published: (2014)

Aging‐associated skeletal muscle defects in HER2/Neu transgenic mammary tumour model
by: Ruizhong Wang, et al.
Published: (2021)

Applicability and interpretation of HER2/Neu & PD-L1 stains in gastrointestinal tract tumours
by: Prasenjit Das, et al.
Published: (2021)

Evaluation of HER2/neu Expression in High-Grade Endometrial Carcinoma and Its Clinicopathological Correlation
by: Soheila Sarmadi, et al.
Published: (2019)

Evaluation of the efficacy of visual, tactile method, caries detector dye, and laser fluorescence in removal of dental caries and confirmation by culture and polymerase chain reaction: An in vivo study
by: Kadandale Sadasiva, et al.
Published: (2019)

Polymerase Chain Reaction: Expedition of a ubiquitous tool
Published: (2011)

Correlation of Serum HER-2/neu Levels with Clinico-Pathological Variables and Tissue Immunohistochemistry in Breast Carcinoma
by: Islam Barkatullah, et al.
Published: (2021)

HER-2/neu over expression in gall bladder adenocarcinoma: A quest for potential therapeutic target
by: Pragya Jain, et al.
Published: (2020)

Cytoplasmic Her2/neu immunohistochemical staining in breast cancer; From a molecular point of view
by: Akbar Safaei, et al.
Published: (2019)

Human papillomavirus deoxyribonucleic acid may not be detected in non-genital benign papillomatous skin lesions by polymerase chain reaction
by: Kamyab Hesari Kambiz, et al.
Published: (2014)

Estudo comparativo entre os métodos LSAB®+ e Herceptest® para a detecção de HER-2/neu em carcinoma de mama A comparative study between LSAB®+ and Herceptest® in the detection of HER-2/neu in breast carcinoma
by: Alexandre de Oliveira Sales, et al.
Published: (2004)